Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Activated protein c blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Cheng, T.
  • Liu, D.
  • Griffin, John
  • Fernandez, J. A.
  • Castellino, F.
  • Rosen, E. D.
  • Fukudome, K.
  • Zlokovic, B. V.

publication date

  • March 2003

journal

  • Nature Medicine  Journal

abstract

  • Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor. It reduces organ damage in animal models of sepsis, ischemic injury and stroke and substantially reduces mortality in patients with severe sepsis. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect is secondary to its anti-coagulant and anti-inflammatory effects. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.

subject areas

  • Animals
  • Antibodies
  • Apoptosis
  • Blood Coagulation Factors
  • Brain
  • Brain Ischemia
  • Caspase 3
  • Caspases
  • Cells, Cultured
  • Endothelium, Vascular
  • Humans
  • In Situ Nick-End Labeling
  • Mice
  • Neuroprotective Agents
  • Oligopeptides
  • Protein C
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Receptor, PAR-1
  • Receptors, Cell Surface
  • Receptors, Thrombin
  • Tumor Suppressor Protein p53
  • bcl-2-Associated X Protein
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1078-8956

Digital Object Identifier (DOI)

  • 10.1038/nm826

PubMed ID

  • 12563316
scroll to property group menus

Additional Document Info

start page

  • 338

end page

  • 342

volume

  • 9

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support